Abstract
Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels.
J R Pauly, M J Marks, S F Robinson, J L van de Kamp and A C Collins
Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 361-369;